Stay updated on Emapalumab Clinical Trial in MAS/sHLH
Sign up to get notified when there's something new on the Emapalumab Clinical Trial in MAS/sHLH page.

Latest updates to the Emapalumab Clinical Trial in MAS/sHLH page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe change is limited to a revision tag update from v3.4.1 to v3.4.2, with no observed impact on the page content, layout, or trial information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no visible page content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedIntroduces a new 'Show glossary' option and makes minor capitalization changes to labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. The revision/version updates from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check42 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3 from the revision history. This update is an administrative change to the page's revision record and does not modify study content.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a dedicated Locations section including Ohio, updating where the study is conducted. Removed the HHS Vulnerability Disclosure footer link and updated the page revision to v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedTwo minor text updates were made: the Publications note now states that items are automatically filled from PubMed and may not be about the study. The revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Emapalumab Clinical Trial in MAS/sHLH
Enter your email address, and we'll notify you when there's something new on the Emapalumab Clinical Trial in MAS/sHLH page.